Design and Evaluation of Gastro-Retentive Floating Tablets of Etidronate disodium
DOI:
https://doi.org/10.22270/ijmspr.v11i1.140Keywords:
Gastro retention, Etidronate disodium, Carbopol 934P, HPMC 4KM, Na-CMC, GRDF, GRFTAbstract
Osteoporosis raises the chance of breaking a bone strength. It is the most frequent cause of fractures in the elderly. The hip, forearm, and back bones are among the bones that break most frequently. Usually, there are no symptoms until a broken bone happens. In order to target site-specific drug release in the upper GIT for a local or systemic effect, GRDDs are a method of extending the gastric residence time. For a very long time, gastro retentive dosage forms (GRDFs) have been used to enhance treatment with a number of significant medications. Paget's disease is a particular kind of bone disease that is treated with etidronate disodium.Bones are weakened and deformed by this disease. To improve its oral bioavailability, etidronate disodium, the most widely used biphosphonate for osteoporosis treatment, was made into gastro retentive dosage form (GRDF) tablets. Carbopol 934P, HPMC 4KM, and Na-CMC at different ratios were used to characterize the effects of GRDF tablets of Etidronate disodium (200 mg) on swelling, floating, and physical integrity. The thickness, friability, hardness, drug content, and in-vitro drug release of the Risedronate GRDF tablets produced in this study were all found to have a prolonged dissolution profile. Oral drug delivery is still the most popular method despite significant advancements in the field because it is simple to administer, therapy is inexpensive, and patient compliance is high.
Keywords: Gastro retention, Etidronate disodium, Carbopol 934P, HPMC 4KM, Na-CMC, GRDF, GRFT.
References
Genant HK, Cooper C, Poor G, Reid I, Ehrlich G, Kanis J, Nordin BC, Barrett-Connor E, Black D, Bonjour JP, Dawson-Hughes B. Interim report and recommendations of the World Health Organization task-force for osteoporosis. Osteoporosis international. 1999;10(4):259. https://doi.org/10.1007/s001980050224 PMid:10692972
Cooper C, Cole ZA, Holroyd CR, Earl SC, Harvey NC, Dennison EM, Melton LJ, Cummings SR, Kanis JA; IOF CSA Working Group on Fracture Epidemiology. Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int. 2011 May;22(5):1277-88. https://doi.org/10.1007/s00198-011-1601-6 PMid:21461721
Sharma S, Nanda A, Singh L. Gastroretentive drug delivery system: an overview. International Journal of Research in Pharmaceutical and Biomedical Sciences. 2011 Sep;2(3):954-8.
https://en.wikipedia.org/wiki/Etidronic_acid
Handbook of Pharmaceutical Excipients, Washington DC, American Pharmaceutical Association / Pharmaceutical Society of Great Britain, 1986,41-42.
Shinde S, Tadwee I, Shahi S. Gastro retentive drug delivery system: A review. Int. J. Pharm. Res. & All. Sci. 2012;1(1):01-13.
Published
How to Cite
Issue
Section
Copyright (c) 2025 Manmeet Kumar , Prashanta Bose , Amar Pal Singh , Ajeet Pal Singh

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

.